[Federal Register Volume 75, Number 171 (Friday, September 3, 2010)]
[Notices]
[Pages 54154-54155]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-22085]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2010-M-0244, FDA-2010-M-0220, FDA-2010-M-0219, FDA-
2010-M-0242, FDA-2010-M-0261, FDA-2010-M-0262, FDA-2010-M-0264, FDA-
2010-M-0294, FDA-2010-M-0285]


Medical Devices; Availability of Safety and Effectiveness 
Summaries for Premarket Approval Applications

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
premarket approval applications (PMAs) that have been approved. This 
list is intended to inform the public of the availability of safety and 
effectiveness summaries of approved PMAs through the Internet and the 
agency's Division of Dockets Management.

ADDRESSES: Submit written requests for copies of summaries of safety 
and effectiveness data to the Division of Dockets Management (HFA-305), 
Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, 
MD 20852. Please cite the appropriate docket number as listed in table 
1 of this document when submitting a written request. See the 
SUPPLEMENTARY INFORMATION section for electronic access to the 
summaries of safety and effectiveness.

FOR FURTHER INFORMATION CONTACT:  Nicole Wolanski, Center for Devices 
and Radiological Health, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 66, rm. 1650, Silver Spring, MD 20993-0002, 301-
796-6570.

SUPPLEMENTARY INFORMATION:

[[Page 54155]]

I. Background

    In the Federal Register of January 30, 1998 (63 FR 4571), FDA 
published a final rule that revised 21 CFR 814.44(d) and 814.45(d) to 
discontinue individual publication of PMA approvals and denials in the 
Federal Register. Instead, the agency now posts this information on the 
Internet on FDA's home page at http://www.fda.gov. FDA believes that 
this procedure expedites public notification of these actions because 
announcements can be placed on the Internet more quickly than they can 
be published in the Federal Register, and FDA believes that the 
Internet is accessible to more people than the Federal Register.
    In accordance with section 515(d)(4) and (e)(2) of the Federal 
Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and 
(e)(2)), notification of an order approving, denying, or withdrawing 
approval of a PMA will continue to include a notice of opportunity to 
request review of the order under section 515(g) of the act. The 30-day 
period for requesting reconsideration of an FDA action under Sec.  
10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA 
begins on the day the notice is placed on the Internet. Section 
10.33(b) provides that FDA may, for good cause, extend this 30-day 
period. Reconsideration of a denial or withdrawal of approval of a PMA 
may be sought only by the applicant; in these cases, the 30-day period 
will begin when the applicant is notified by FDA in writing of its 
decision.
    The regulations provide that FDA publish a quarterly list of 
available safety and effectiveness summaries of PMA approvals and 
denials that were announced during that quarter. The following is a 
list of approved PMAs for which summaries of safety and effectiveness 
were placed on the Internet from April 1, 2010, through June 30, 2010. 
There were no denial actions during this period. The list provides the 
manufacturer's name, the product's generic name or the trade name, and 
the approval date.

    Table 1.--List of Safety and Effectiveness Summaries for Approved PMAs Made Available From April 1, 2010,
                                              through June 30, 2010
----------------------------------------------------------------------------------------------------------------
 PMA No. Docket No.         Applicant                     TRADE NAME                       Approval Date
----------------------------------------------------------------------------------------------------------------
P090018               Envoy Medical Corp.   ESTEEM TOTALLY IMPLANTABLE HEARING     March 17, 2010
FDA-2010-M-0244                              SYSTEM
----------------------------------------------------------------------------------------------------------------
P080029               Interventional        QUICK CLOSE VASCULAR SUTURING SYSTEM   April 8, 2010
FDA-2010-M-0220        Therapies, LLC
----------------------------------------------------------------------------------------------------------------
P090022               Lenstec, Inc.         SOFTEC HD POSTERIOR CHAMBER            April 12, 2010
FDA-2010-M-0219                              INTRAOCULAR LENS (PCIOL)
----------------------------------------------------------------------------------------------------------------
P080032               Asthmatix, Inc.       ALAIR BRONCHIAL THERMOPLASTY           April 27, 2010
FDA-2010-0242
----------------------------------------------------------------------------------------------------------------
P090007               Roche Diagnostics     ELECSYS ANTI-HCV IMMUNOASSAY AND       April 29, 2010
FDA-2010-M-0261        Corp.                 ELECSYS PRECICONTROL ANTI-HCV FOR
                                             USE ON THE COBAS E411 IMMUNOASSAY
                                             ANALYZER
----------------------------------------------------------------------------------------------------------------
P090008               Roche Diagnostics     ELECSYS ANTI-HCV IMMUNOASSAY AND       April 29, 2010
FDA-2010-M-0262        Corp.                 ELECSYS PRECICONTROL ANTI-HCV FOR
                                             USE ON THE COBAS E601 IMMUNOASSAY
                                             ANALYZER
----------------------------------------------------------------------------------------------------------------
P090009               Roche Diagnostics     ELECSYS ANTI-HCV IMMUNOASSAY AND       April 29, 2010
FDA-2010-M-0264        Corp.                 ELECSYS PRECICONTROL ANTI-HCV FOR
                                             USE ON THE MODULAR ANALYTICS E170
                                             ANALYZER
----------------------------------------------------------------------------------------------------------------
P050027               Karl Storz            PHOTODYNAMIC DIAGNOSTIC D-LIGHT C      May 28, 2010
FDA-2010-M-0294        endoscopy--America,
                       Inc.
----------------------------------------------------------------------------------------------------------------
P060029               Ethicon, Inc.         OMNEX SURGICAL SEALANT                 June 3, 2010
FDA-2010-M-0285
----------------------------------------------------------------------------------------------------------------

II. Electronic Access

    Persons with access to the Internet may obtain the documents at 
http://www.fda.gov/cdrh/pmapage.html.

    Dated: August 31, 2010.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices and Radiological Health.
[FR Doc. 2010-22085 Filed 9-2-10; 8:45 am]
BILLING CODE 4160-01-S